Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action? [electronic resource]
Producer: 20071106Description: 1443-9 p. digitalISSN:- 0269-2813
- Annexin A5 -- pharmacology
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Apoptosis -- drug effects
- Blotting, Western -- methods
- Colitis, Ulcerative -- drug therapy
- Colonic Neoplasms -- metabolism
- Down-Regulation
- Enzyme Inhibitors -- pharmacology
- Gene Expression -- drug effects
- Humans
- Immunohistochemistry -- methods
- Mesalamine -- pharmacology
- Proto-Oncogene Proteins c-myc -- metabolism
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.